ROYAL BANK OF CANADA - MONOPAR THERAPEUTICS INC ownership

MONOPAR THERAPEUTICS INC's ticker is MNPR and the CUSIP is 61023L108. A total of 12 filers reported holding MONOPAR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MONOPAR THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$7,000
-22.2%
5,000
+21.5%
0.00%
Q2 2022$9,000
-10.0%
4,1160.0%0.00%
Q1 2022$10,000
-23.1%
4,1160.0%0.00%
Q4 2021$13,000
-35.0%
4,1160.0%0.00%
Q3 2021$20,000
-33.3%
4,116
-19.8%
0.00%
Q2 2021$30,000
-47.4%
5,130
-43.8%
0.00%
Q1 2021$57,0009,1300.00%
Other shareholders
MONOPAR THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
American Portfolios Advisors 700$1,6100.00%
ROYAL BANK OF CANADA 4,116$9,0000.00%
VANGUARD GROUP INC 99,879$230,0000.00%
UBS Group AG 19,561$45,0000.00%
IFP Advisors, Inc 500$13,0000.00%
FMR LLC 10$00.00%
WELLS FARGO & COMPANY/MN 29$00.00%
NORTHERN TRUST CORP 35,203$81,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 39,171$85,0000.00%
View complete list of MONOPAR THERAPEUTICS INC shareholders